SSRM heads into post-earnings trading with a cleaner balance sheet story than the market had priced in — and a major asset sale on the horizon that reshapes the investment thesis entirely.
The Q1 beat was unambiguous. Adjusted EPS came in at $1.15 against a Street estimate of $0.86, a 34% beat. Revenue of $581.8M topped the $539.4M consensus. The EPS surprise rank of 69 — sitting in the top third of the universe on a consistent basis — reinforces a pattern of management under-promising. Gold prices did the heavy lifting, with the commodity tailwind amplifying operating leverage across the portfolio.
The structural story is the Copler divestiture. Management guided that the sale of the Turkish Copler mine should close before end of Q3 2026, generating roughly $1.5B in cash proceeds. The company already carries net cash of over $2.3B on its balance sheet. That combination would leave SSRM sitting on a substantial cash pile relative to its enterprise value of approximately $8.7B — at an EV/EBITDA near 4x on forward estimates, valuation looks undemanding for a gold producer reporting this kind of free cash flow. Operating cash flow came in at $1.15B against capex of $394M, leaving meaningful free cash flow to deploy.
Short interest is light and the lending market is wide open — not a story here at all. SI is just 0.5% of free float, with borrow availability extremely loose and cost to borrow below 1%. The ORTEX short score of 26.8 confirms there is no meaningful short-side pressure. The modest 12.5% decline in the stock over the past month was broad sector weakness rather than stock-specific concern; TSX gold peers , , and fell 7%, 5.9%, and 6.8% respectively over the same week. BlackRock holds 8.8% of the company, with Van Eck and Mirae Asset rounding out the top-three institutional positions — a base of gold-specialist and passive capital that tends to be sticky.
The earnings print is now in. What the market must evaluate is whether the Copler cash proceeds will be returned to shareholders, redeployed in M&A, or held as a war chest — and whether management's guidance on the remaining asset base justifies holding premium to peers at a moment when gold prices are both the company's biggest friend and its biggest macro dependency.
See the live data behind this article on ORTEX.
Open SSRM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
